Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Koulousakis, Philipposa; c | Andrade, Pablob; c | Visser-Vandewalle, Veerlea; c | Sesia, Thibauta; c; *
Affiliations: [a] Department of Stereotactic and Functional Neurosurgery, University Hospital of Cologne, Germany | [b] Department of Neurosurgery, University Hospital of Cologne, Germany | [c] European Graduate School of Neuroscience, Maastricht, The Netherlands
Correspondence: [*] Correspondence to: Dr. Thibaut Sesia, Department of Stereotactic and Functional Neurosurgery, University Hospital of Cologne, Kerpener Str. 62, D – 50937, Cologne, Germany. Tel.: +0049 221 478 82772; E-mail: thibaut.sesia@uk-koeln.de.
Abstract: The nucleus basalis of Meynert (nbM) was first described at the end of the 19th century and named after its discoverer, Theodor Meynert. The nbM contains a large population of cholinergic neurons that project their axons to the entire cortical mantle, the olfactory tubercle, and the amygdala. It has been functionally associated with the control of attention and maintenance of arousal, both key functions for appropriate learning and memory formation. This structure is well-conserved across vertebrates, although its degree of organization varies between species. Since early in the investigation of its functional and pathological significance, its degeneration has been linked to various major neuropsychiatric disorders. For instance, Lewy bodies, a hallmark in the diagnosis of Parkinson’s disease, were originally described in the nbM. Since then, its involvement in other Lewy body and dementia-related disorders has been recognized. In the context of recent positive outcomes following nbM deep brain stimulation in subjects with dementia-associated disorders, we review the literature from an historical perspective focusing on how the nbM came into focus as a promising therapeutic option for patients with Alzheimer’s disease. Moreover, we will discuss what is needed to further develop and widely implement this approach as well as examine novel medical indications for which nbM deep brain stimulation may prove beneficial.
Keywords: Acetylcholine, Alzheimer’s disease, deep brain stimulation, nucleus basalis of Meynert
DOI: 10.3233/JAD-180133
Journal: Journal of Alzheimer's Disease, vol. 69, no. 4, pp. 905-919, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl